Ahmed Sajeela, Ahmed Naseer, Rungatscher Alessio, Linardi Daniele, Kulsoom Bibi, Innamorati Giulio, Meo Sultan Ayoub, Gebrie Mebratu Alebachew, Mani Romel, Merigo Flavia, Guzzo Flavia, Faggian Giuseppe
Department of Surgery, Division of Cardiac Surgery, University of Verona, 37129 Verona, Italy.
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi 74800, Pakistan.
Antioxidants (Basel). 2020 Feb 18;9(2):167. doi: 10.3390/antiox9020167.
Consumption of flavonoid-rich nutraceuticals has been associated with a reduction in coronary events. The present study analyzed the effects of cocoa flavonols on myocardial injury following acute coronary ischemia-reperfusion (I/R). A commercially available cocoa extract was identified by chromatographic mass spectrometry. Nineteen different phenolic compounds were identified and 250 mg of flavan-3-ols (procyanidin) were isolated in 1 g of extract. Oral administration of cocoa extract in incremental doses from 5 mg/kg up to 25 mg/kg daily for 15 days in Sprague Dawley rats ( = 30) produced a corresponding increase of blood serum polyphenols and become constant after 15 mg/kg. Consequently, the selected dose (15 mg/kg) of cocoa extract was administered orally daily for 15 days in a treated group ( = 10) and an untreated group served as control ( = 10). Both groups underwent surgical occlusion of the left anterior descending coronary artery and reperfusion. Cocoa extract treatment significantly reversed membrane peroxidation, nitro-oxidative stress, and decreased inflammatory markers (IL-6 and NF-kB) caused by myocardial I/R injury and enhanced activation of both p-Akt and p-Erk1/2. Daily administration of cocoa extract in rats is protective against myocardial I/R injury and attenuate nitro-oxidative stress, inflammation, and mitigates myocardial apoptosis.
食用富含类黄酮的营养保健品与冠状动脉事件的减少有关。本研究分析了可可黄酮醇对急性冠状动脉缺血再灌注(I/R)后心肌损伤的影响。通过色谱质谱法鉴定了一种市售可可提取物。鉴定出19种不同的酚类化合物,在1克提取物中分离出250毫克黄烷-3-醇(原花青素)。在斯普拉格-道利大鼠(n = 30)中,每天以5毫克/千克至25毫克/千克的递增剂量口服可可提取物,持续15天,血清多酚相应增加,在15毫克/千克后趋于稳定。因此,在治疗组(n = 10)中,每天口服选定剂量(15毫克/千克)的可可提取物,持续15天,未治疗组作为对照(n = 10)。两组均接受左冠状动脉前降支结扎和再灌注手术。可可提取物治疗显著逆转了心肌I/R损伤引起的膜过氧化、硝基氧化应激,并降低了炎症标志物(IL-6和NF-κB),增强了p-Akt和p-Erk1/2的激活。在大鼠中每日给予可可提取物可保护心肌免受I/R损伤,减轻硝基氧化应激、炎症,并减轻心肌细胞凋亡。